Explore

Brand - InSCREENeX : Overview | A2A

OverviewProducts
Vegan / plant-based / cruelty-free is not applicable
Product Range The SCREENflex™ technology creates stable transgenic cell lines 50-70% faster than conventional recombinant techniques.
The CI-SCREEN™ technology creates physiological relevant cell systems in sufficient quantity for use in drug development campaigns.
CountryGermany
CompanyInSCREENeX
Sustainability or Impact or Vision Statement
About